Advancing Treatments to Save Lives and Reduce the Risk of COVID-19   [open pdf - 0B]

From the Document: "Many potentially beneficial treatments for COVID-19 [coronavirus disease] are in various stages of development. Patients facing the risk of serious complications from the virus and no therapeutic alternatives will understandably want access to them. We need to determine which treatments work best to advance safe and effective products to market efficiently, while providing the best possible care for patients with COVID-19 and enabling access to promising treatments for patients who might benefit from them now. To accomplish these goals, we can support large scale access to different drugs that have shown they may be effective against the coronavirus in a framework that enables us to collect good information to determine which medicines are working best for patients, and ultimately merit full FDA approval. At the same time, we can advance treatments that can help protect people from becoming infected with coronavirus in the first place. We also need more tools for early detection of the virus so we can prevent future outbreaks. Building on approaches taken in prior public health emergencies and on improved capabilities for data collection and analysis, all these things are possible to address the COVID-19 pandemic."

Duke University
Retrieved From:
American Enterprise Institute: https://www.aei.org/
Media Type:
Help with citations